Corporate News

Myconostica Ltd appoints John Jeans as Non Executive Director

17th July 2008

Myconostica Ltd, a UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, is delighted to announce the appointment of John Jeans, a senior figure in the diagnostics industry and currently President of GE Healthcare Life Sciences’ ... Read More

Myconostica Ltd completes £5.4 million round with £1m from UMIP Premier Fund financing to bring advanced medical diagnostics for life-threatening infections to market

20th May 2008

Myconostica Ltd, a Manchester UK-based medical diagnostic company which specialises in rapid and highly specific tests for life-threatening fungal infections, today announces that it has completed the third close of a $10.8 million (£5.4M) round of financing with a £1m investment from the UMIP Premier ... Read More

Myconostica Ltd Closes Oversubscribed $7.7 Million Round and Establishes US Headquarters in Charleston

9th April 2008

... Read More

Amphion Innovations Partner Company Myconostica Limited Closes £570,000 Round Financing

30th July 2007

Amphion Innovations plc today announces that its Partner Company, Myconostica Limited, a Manchester University spin-out that specialises in a new type of ‘molecular’ diagnostic test for infectious diseases, particularly life-threatening respiratory fungal infections, has raised £570,000 at ... Read More

Myconostica Ltd appoints Dr Paul Bowyer to its Scientific Advisory Board

29th March 2007

Manchester, England - Dr Paul Bowyer was appointed yesterday to the Scientific Advisory Board of Myconostica. Dr Bowyer brings great technical expertise in the area of fungal molecular biology to the company. As a close working colleague of Professor Denning, Myconostica’s Founder, his skill set is quite ... Read More

MYCONOSTICA LTD ANNOUNCES £1 MILLION INVESTMENT BY AMPHION INNOVATIONS PLC

27th November 2006

Manchester, England - Myconostica Ltd announced today that it had secured investment of £1m from Amphion Innovations plc (LSE:AMP) ("Amphion") to underwrite the development and launch of its first product... Read More

Myconostica wins Biotechnology Start Up of the Year Award.

16th November 2006

At an awards ceremony in Mere, Cheshire last night, Myconostica was awarded the prestigious Biotechnology Start Up of the Year Award for 2006. The award recognizes the quality of the product or service and its potential for growth. The award was sponsored by leading national law firm Addleshaw Goddard and the ... Read More

Myconostica Ltd appoints Dr John Thornback as Non-Executive Director

31st October 2006

Manchester, England - Myconostica Ltd announced today that it will appoint Dr John Thornback as Non-Executive Director with special responsibility for pre-clinical development and operations... Read More